Skip to main content
Premium Trial:

Request an Annual Quote

Transgenomic Gets SBIR Grant to Develop Technology for Whole-Genome Analysis

NEW YORK (GenomeWeb News) – Transgenomic today said that it has received a $100,000 Small Business Innovation Research grant to support the development of the firm’s Surveyor Endonuclease Adaptor-ligated Libraries technology.
The SEAL technology is a high-throughput method for whole-genome analysis. The Omaha, Neb.-based firm said that it can identify DNA variations between a reference genome and a test genome and could potentially reduce the cost of whole-genome analysis of such variations to under $10,000.
By focusing on regions of DNA variation, the SEAL technology eliminates the sequencing of vast amounts of non-variant DNA, said Transgenomic, but it also is not limited to assessment of known common SNPs.
Craig Tuttle, president and CEO of Transgenomic, said that the grants supports the firm’s belief that its technology “will have a significant impact on whole-genome analysis for pharmacogenomic studies in personalized medicine and bacterial drug resistance research.”
The grant period has a duration of six months.

The Scan

Comfort of Home

The Guardian reports that AstraZeneca is to run more clinical trials from people's homes with the aim of increasing participant diversity.

Keep Under Control

Genetic technologies are among the tools suggested to manage invasive species and feral animals in Australia, Newsweek says.

Just Make It

The New York Times writes that there is increased interest in applying gene synthesis to even more applications.

Nucleic Acids Research Papers on OncoDB, mBodyMap, Genomicus

In Nucleic Acids Research this week: database to analyze large cancer datasets, human body microbe database, and more.